Cancer is a global problem with 14.1 million new cases occurring annually and an expected increase of 68% by 2030. Ensuring effective and safe treatment remains a significant challenge for healthcare organisations. Studies have shown proton therapy to be effective in treating many types of tumours, including tumours of the prostate, brain, head and neck, central nervous system, lung, and gastrointestinal system as well as cancers that cannot be removed completely by surgery. Proton therapy is the most advanced type of external-beam radiation therapy; it uses protons - positively charged particles - at high energy to destroy cancer cells. Proton therapy is routinely used for cancer treatment. However widespread adoption is severely limited by the sheer size and expense of the systems. There are currently only 66 operational proton therapy facilities in the world, addressing only 3-5% of clinical demand. HIL Applied Medical overcomes these limitations through its ultra-compact and high-performance proton therapy system that overcomes these limitations saving up to 50% space and reducing costs by up to 80%.